Hill-Rom Holdings, Inc. (NYSE:HRC) – Northcoast Research decreased their FY2019 earnings per share estimates for shares of Hill-Rom in a research note issued to investors on Thursday, July 11th. Northcoast Research analyst D. Keiser now expects that the medical technology company will earn $5.03 per share for the year, down from their prior estimate of $5.05. Northcoast Research also issued estimates for Hill-Rom’s Q4 2019 earnings at $1.66 EPS and Q2 2020 earnings at $1.24 EPS.
Hill-Rom (NYSE:HRC) last announced its quarterly earnings results on Friday, April 26th. The medical technology company reported $1.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.03. Hill-Rom had a net margin of 7.93% and a return on equity of 21.30%. The firm had revenue of $714.20 million during the quarter, compared to the consensus estimate of $705.59 million. During the same period last year, the firm posted $1.05 EPS. The firm’s quarterly revenue was up .5% on a year-over-year basis.
Shares of HRC opened at $104.01 on Friday. The firm has a 50 day moving average of $102.64. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.27 and a current ratio of 1.69. The company has a market capitalization of $7.01 billion, a price-to-earnings ratio of 21.90, a P/E/G ratio of 1.81 and a beta of 0.92. Hill-Rom has a twelve month low of $81.82 and a twelve month high of $108.68.
The company also recently declared a quarterly dividend, which was paid on Friday, June 28th. Shareholders of record on Friday, June 21st were paid a dividend of $0.21 per share. The ex-dividend date of this dividend was Thursday, June 20th. This represents a $0.84 annualized dividend and a yield of 0.81%. Hill-Rom’s payout ratio is presently 17.68%.
A number of institutional investors have recently bought and sold shares of HRC. Hanseatic Management Services Inc. acquired a new position in shares of Hill-Rom in the 1st quarter valued at about $30,000. Sageworth Trust Co acquired a new position in shares of Hill-Rom during the first quarter valued at approximately $32,000. Financial Gravity Wealth Inc. acquired a new position in shares of Hill-Rom during the first quarter valued at approximately $53,000. Osborn Williams & Donohoe LLC acquired a new position in shares of Hill-Rom during the first quarter valued at approximately $53,000. Finally, Rehmann Capital Advisory Group raised its holdings in shares of Hill-Rom by 82.1% during the first quarter. Rehmann Capital Advisory Group now owns 539 shares of the medical technology company’s stock valued at $57,000 after acquiring an additional 243 shares during the last quarter. Institutional investors and hedge funds own 81.29% of the company’s stock.
Hill-Rom Company Profile
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Featured Article: Bear Market – How and Why They Occur
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.